Aurobindo Pharma reports 40% rise in Q4; stocks up 4%
The company's net profit for the January-March quarter rose to Rs 5.63 billion ($83.9 million) from Rs 4.03 billion a year earlier, Aurobindo said in a statement late on Monday.
Aurobindo Pharma, which gets about 85% of its sales from international markets, said it received US approval to sell 17 new products in the fourth quarter (Q4). Image Source: Official Website